SRDX Relative Valuation
SRDX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SRDX is overvalued; if below, it's undervalued.
Historical Valuation
Surmodics Inc (SRDX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -36.45. The fair price of Surmodics Inc (SRDX) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 42.99 USD , Surmodics Inc is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：42.99
Fair
Undervalued
-116.16
PE
1Y
3Y
5Y
Trailing
Forward
49.43
EV/EBITDA
Surmodics Inc. (SRDX) has a current EV/EBITDA of 49.43. The 5-year average EV/EBITDA is 18.10. The thresholds are as follows: Strongly Undervalued below -76.87, Undervalued between -76.87 and -29.38, Fairly Valued between 65.59 and -29.38, Overvalued between 65.59 and 113.07, and Strongly Overvalued above 113.07. The current Forward EV/EBITDA of 49.43 falls within the Historic Trend Line -Fairly Valued range.
-81.20
EV/EBIT
Surmodics Inc. (SRDX) has a current EV/EBIT of -81.20. The 5-year average EV/EBIT is -35.35. The thresholds are as follows: Strongly Undervalued below -353.76, Undervalued between -353.76 and -194.56, Fairly Valued between 123.86 and -194.56, Overvalued between 123.86 and 283.06, and Strongly Overvalued above 283.06. The current Forward EV/EBIT of -81.20 falls within the Historic Trend Line -Fairly Valued range.
5.03
PS
Surmodics Inc. (SRDX) has a current PS of 5.03. The 5-year average PS is 4.48. The thresholds are as follows: Strongly Undervalued below 1.72, Undervalued between 1.72 and 3.10, Fairly Valued between 5.86 and 3.10, Overvalued between 5.86 and 7.24, and Strongly Overvalued above 7.24. The current Forward PS of 5.03 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Surmodics Inc. (SRDX) has a current P/OCF of 0.00. The 5-year average P/OCF is 25.85. The thresholds are as follows: Strongly Undervalued below -189.11, Undervalued between -189.11 and -81.63, Fairly Valued between 133.33 and -81.63, Overvalued between 133.33 and 240.81, and Strongly Overvalued above 240.81. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
665.62
P/FCF
Surmodics Inc. (SRDX) has a current P/FCF of 665.62. The 5-year average P/FCF is -399.10. The thresholds are as follows: Strongly Undervalued below -3916.57, Undervalued between -3916.57 and -2157.83, Fairly Valued between 1359.64 and -2157.83, Overvalued between 1359.64 and 3118.37, and Strongly Overvalued above 3118.37. The current Forward P/FCF of 665.62 falls within the Historic Trend Line -Fairly Valued range.
Surmodics Inc (SRDX) has a current Price-to-Book (P/B) ratio of 5.52. Compared to its 3-year average P/B ratio of 4.02 , the current P/B ratio is approximately 37.50% higher. Relative to its 5-year average P/B ratio of 4.30, the current P/B ratio is about 28.54% higher. Surmodics Inc (SRDX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -1.00%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -0.64% , the current FCF yield is about -100.00% lower.
5.52
P/B
Median3y
4.02
Median5y
4.30
-0.58
FCF Yield
Median3y
-1.00
Median5y
-0.64
Competitors Valuation Multiple
The average P/S ratio for SRDX's competitors is , providing a benchmark for relative valuation. Surmodics Inc Corp (SRDX) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -2.55%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SRDX increased by 8.54% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -24.96 to -34.66.
The secondary factor is the Revenue Growth, contributed -2.55%to the performance.
Overall, the performance of SRDX in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Surmodics Inc (SRDX) currently overvalued or undervalued?
What is Surmodics Inc (SRDX) fair value?
How does SRDX's valuation metrics compare to the industry average?
What is the current P/B ratio for Surmodics Inc (SRDX) as of Dec 05 2025?
What is the current FCF Yield for Surmodics Inc (SRDX) as of Dec 05 2025?
What is the current Forward P/E ratio for Surmodics Inc (SRDX) as of Dec 05 2025?